OUR SPECIALTY

orphan-drugs_

pharmethıca

Oncology and Hematology

Cancer and hematological disorders encompass a diverse group of diseases characterized by abnormal and uncontrolled cell growth or dysfunction of blood and bone marrow components. While cancers affect tissues and organs throughout the body, hematological conditions involve blood cells, bone marrow, and the lymphatic system, including disorders such as leukemias, lymphomas, and coagulation abnormalities. Both oncology and hematology remain among the most research-intensive and rapidly evolving fields in modern medicine, with ongoing advancements in targeted therapies, immunotherapies, and precision medicine approaches. PharmEthica is committed to support patients by ensuring access to rare disease medicines of oncology and hematology therapeutic areas.

pharmethıca

Orphan Drugs

Orphan drugs, also known as rare disease drugs, are medical products intended for the diagnosis, prevention, or treatment of life-threatening or very serious diseases or conditions that are rare. If a disease affects fewer than 200,000 people, it is also classified as rare, or an orphan disease. The reason these drugs are called “orphan” is that, under normal market conditions, the pharmaceutical industry shows very little interest in developing and marketing products for only a small number of patients. For drug companies, the extremely high cost of bringing a medical product to market cannot be offset by the expected sales of the product.

onkoloji

pharmethıca

Plasma & Blood Products

Plasma-derived medicinal products (PDMPs) are therapeutic preparations obtained from human plasma through highly specialized and strictly controlled manufacturing processes. These products contain essential proteins such as albumin, clotting factors, and immunoglobulins, which play a critical role in the treatment and management of numerous acute and chronic, life-threatening conditions.

At PharmEthica, we are dedicated to ensuring the availability of high-quality plasma and blood products that meet international standards of safety, purity, and efficacy. Through our reliable supply network and commitment to regulatory compliance, we support healthcare providers in delivering life-saving therapies to patients in need. Our field force covers more than 90% of physicians and we are the market leader at some specific blood products. 

plasma-ve-kan-urunleri
immunoloji

pharmethıca

Immunology

Our bodies are continuously exposed to various biological and non-biological substances from both internal and external environments. Some of these, such as bacteria, viruses, and fungi, can cause disease, while others—like allergens—are typically harmless but may trigger hypersensitivity reactions in certain individuals. Allergic diseases arise from complex interactions among genetic, environmental, and immunological factors. Immunotherapy products play a key role in the management of such conditions by modulating the immune system and promoting tolerance, effectively teaching the body to respond appropriately to allergens.

To discuss collaboration or representation opportunities, we are here

PharmEthica © 2023 All Rights Reserved.

Design: